Diligent family history to detect a mitochondrial disorder in disguise: Lessons from a case of myoclonic epilepsy
Mitochondrial disorders often present with ataxia, myoclonus, and epilepsy. Valproic acid may be selected for treating myoclonus if it is the presenting feature. While it is efficacious in suppressing cortical myoclonus, valproic acid is a known mitochondrial toxin and, therefore, not recommended. W...
Saved in:
| Main Authors: | Suvorit S. Bhowmick, Radhay Parikh, Pratishtha Shrivastav |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
| Series: | Annals of Movement Disorders |
| Subjects: | |
| Online Access: | https://doi.org/10.4103/aomd.aomd_22_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Opsoclonus-Myoclonus Syndrome in Children: Modern Data
by: Irina F. Fedoseeva, et al.
Published: (2025-02-01) -
Decoding the genetic blueprints of neurological disorders: disease mechanisms and breakthrough gene therapies
by: Umar Saeed, et al.
Published: (2025-04-01) -
Etiological Factors of Opsoclonus Myoclonus Ataxia Syndrome: A Single Center Experience with Eight Children
by: Veysel Gök, et al.
Published: (2022-12-01) -
Machine Learning-Based Scoring System to Predict the Risk and Severity of Ataxic Speech Using Different Speech Tasks
by: Bipasha Kashyap, et al.
Published: (2023-01-01) -
Onconeural antibody-associated cerebellar ataxia: An analysis
by: Rohan Mahale, et al.
Published: (2024-05-01)